X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (292938) 292938
Publication (26599) 26599
Patent (22640) 22640
Newspaper Article (9943) 9943
Newsletter (9026) 9026
Book Review (2072) 2072
Book Chapter (1357) 1357
Magazine Article (718) 718
Book / eBook (498) 498
Conference Proceeding (422) 422
Trade Publication Article (264) 264
Dissertation (169) 169
Transcript (111) 111
Government Document (79) 79
Report (57) 57
Web Resource (57) 57
Data Set (53) 53
Reference (36) 36
Paper (21) 21
Journal / eJournal (3) 3
Streaming Video (3) 3
Presentation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (138383) 138383
humans (127313) 127313
index medicus (120551) 120551
enzymes (103780) 103780
male (88023) 88023
female (62840) 62840
rats (55031) 55031
mice (49399) 49399
enzyme-linked immunosorbent assay (43982) 43982
enzyme inhibitors - pharmacology (39920) 39920
dose-response relationship, drug (36926) 36926
biochemistry & molecular biology (36842) 36842
pharmacology & pharmacy (36230) 36230
biochemistry (33496) 33496
microbiology (31822) 31822
analysis (31519) 31519
proteins (29603) 29603
chemistry (28629) 28629
research (28605) 28605
adult (25536) 25536
expression (25115) 25115
middle aged (25000) 25000
enzymology (24113) 24113
oxidative stress (23367) 23367
wine (22907) 22907
beer (22755) 22755
metallurgy (22674) 22674
vinegar (22663) 22663
spirits (22643) 22643
mutation or genetic engineering (22640) 22640
apoptosis (22256) 22256
physiological aspects (22226) 22226
cell biology (21689) 21689
cells, cultured (20808) 20808
time factors (19268) 19268
oncology (19265) 19265
cancer (19122) 19122
immunology (18937) 18937
metabolism (18624) 18624
gene expression (17799) 17799
health aspects (17656) 17656
toxicology (17635) 17635
research article (17243) 17243
aged (17058) 17058
neurosciences (16665) 16665
rats, sprague-dawley (15845) 15845
medicine (15788) 15788
rodents (15455) 15455
activation (15323) 15323
cells (15104) 15104
inflammation (14616) 14616
antioxidants (14456) 14456
inhibition (14388) 14388
enzyme activation (14194) 14194
phosphorylation (14192) 14192
article (14047) 14047
enzyme activation - drug effects (13927) 13927
culture media (13841) 13841
rats, wistar (13819) 13819
cell line (13611) 13611
cell line, tumor (13327) 13327
multidisciplinary sciences (13289) 13289
liver (13147) 13147
compositions thereof (13078) 13078
microorganisms or enzymes (13078) 13078
propagating, preserving or maintaining microorganisms (13078) 13078
in-vitro (12985) 12985
physiology (12904) 12904
peptides (12844) 12844
studies (12710) 12710
signal transduction (12502) 12502
care and treatment (12343) 12343
medicine, research & experimental (12028) 12028
kinetics (12010) 12010
human necessities (11912) 11912
compositions or test papers therefor (11791) 11791
condition-responsive control in microbiological orenzymological processes (11791) 11791
measuring or testing processes involving enzymes, nucleicacids or microorganisms (11791) 11791
processes of preparing such compositions (11791) 11791
disease models, animal (11523) 11523
hygiene (11344) 11344
blotting, western (11330) 11330
medical or veterinary science (11269) 11269
endocrinology & metabolism (11187) 11187
science (10889) 10889
preparations for medical, dental, or toilet purposes (10860) 10860
apoptosis - drug effects (10762) 10762
physics (10471) 10471
biotechnology & applied microbiology (10402) 10402
organic chemistry (10263) 10263
genetic aspects (10209) 10209
testing (10193) 10193
toxicity (10051) 10051
nitric oxide (9977) 9977
disease (9943) 9943
life sciences (9885) 9885
enzyme inhibitors (9775) 9775
kinases (9771) 9771
gene-expression (9721) 9721
measuring (9718) 9718
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (300) 300
UofT at Mississauga - Stacks (40) 40
UTL at Downsview - May be requested (35) 35
Engineering & Comp. Sci. - Stacks (33) 33
Online Resources - Online (20) 20
Chemistry (A D Allen) - Stacks (16) 16
Collection Dvlpm't (Acquisitions) - Vendor file (15) 15
UofT at Scarborough - Stacks (15) 15
Collection Dvlpm't (Acquisitions) - Closed Orders (11) 11
Earth Sciences (Noranda) - Stacks (11) 11
Gerstein Science - Reference (3) 3
UofT at Scarborough - Withdrawn (3) 3
Royal Ontario Museum - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Criminology - Stacks (1) 1
Engineering & Comp. Sci. - May be requested in 6-10 wks (1) 1
Engineering & Comp. Sci. - Missing (1) 1
Engineering & Comp. Sci. - Reference (1) 1
Gerstein Science - Missing (1) 1
Gerstein Science - Not Returned (1) 1
Mt Sinai Hospital - Pathology (1) 1
Online (1) 1
Online Resources - Pharmacy (1) 1
Physics - Stacks (1) 1
Robarts - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Mississauga - Reference (1) 1
UofT at Scarborough - May be requested in 6-10 wks (1) 1
UofT at Scarborough - Storage (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (331600) 331600
French (15774) 15774
German (4689) 4689
Russian (1769) 1769
Chinese (1220) 1220
Japanese (693) 693
Spanish (474) 474
Polish (204) 204
Portuguese (168) 168
Italian (157) 157
Danish (125) 125
Korean (109) 109
Norwegian (91) 91
Ukrainian (90) 90
Hungarian (77) 77
Czech (67) 67
Bulgarian (65) 65
Turkish (47) 47
Swedish (46) 46
Dutch (40) 40
Croatian (38) 38
Hebrew (35) 35
Persian (31) 31
Romanian (29) 29
Greek (26) 26
Slovenian (25) 25
Lithuanian (18) 18
Finnish (15) 15
Slovak (14) 14
Arabic (12) 12
Serbian (10) 10
Indonesian (5) 5
Icelandic (4) 4
Bosnian (3) 3
Afrikaans (2) 2
Estonian (2) 2
Latvian (1) 1
Malay (1) 1
Moldavian (1) 1
Ndonga (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2007, Volume 357, Issue 25, pp. 2562 - 2575
This study examines the toxicity of immunosuppressive regimens in renal-transplant recipients. A regimen containing mycophenolate mofetil, daclizumab, low-dose... 
MULTICENTER TRIAL | MEDICINE, GENERAL & INTERNAL | CYCLOSPORINE MICROEMULSION | EFFICACY | KIDNEY-TRANSPLANTATION | IMMUNOSUPPRESSION | ALLOGRAFT RECIPIENTS | TACROLIMUS | MYCOPHENOLATE-MOFETIL | SIROLIMUS | NEPHROTOXICITY | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Adrenal Cortex Hormones - therapeutic use | Enzyme Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized | Calcineurin Inhibitors | Treatment Failure | Adult | Diabetes Mellitus - etiology | Female | Drug Therapy, Combination | Mycophenolic Acid - administration & dosage | Immunosuppressive Agents - administration & dosage | Sirolimus - adverse effects | Tacrolimus - administration & dosage | Prednisone - administration & dosage | Glomerular Filtration Rate | Graft Rejection - prevention & control | Kaplan-Meier Estimate | Kidney Transplantation | Immunoglobulin G - administration & dosage | Opportunistic Infections | Sirolimus - administration & dosage | Mycophenolic Acid - analogs & derivatives | Antibodies, Monoclonal - administration & dosage | Cyclosporine - administration & dosage | Immunosuppressive Agents - adverse effects | Aged | Adrenal Cortex Hormones - administration & dosage | Transplantation | Corticosteroids | Kidneys | Research | Health aspects | Immunosuppressive agents | Medical research | Immunology | Inhibitor drugs | Transplants & implants | Toxicity | Inhibidors enzimàtics | Posologia | Ús terapèutic | Corticosteroides | Rebuig (Biologia) | Posology | Therapeutic use | Immunosupressive agents | Graft rejection | Trasplantament renal | Enzyme inhibitors | Adrenocortical hormones | Immunosupressors | Kidney transplantation | Tacrolimus: administration & dosage | Medical and Health Sciences | Graft Rejection: prevention & control | Immunoglobulin G: administration & dosage | Medicin och hälsovetenskap | Mycophenolic Acid: administration & dosage | Antibodies | Klinisk medicin | Monoclonal: administration & dosage | Prednisone: administration & dosage | Adrenal Cortex Hormones: administration & dosage | Immunosuppressive Agents: administration & dosage | Mycophenolic Acid: analogs & derivatives | Sirolimus: administration & dosage | Cyclosporine: administration & dosage | Calcineurin: antagonists & inhibitors | Diabetes Mellitus: etiology | Urologi och njurmedicin | Sirolimus: adverse effects | Adrenal Cortex Hormones: therapeutic use | Enzyme Inhibitors: administration & dosage | Immunosuppressive Agents: adverse effects | Clinical Medicine | Immunosuppressive Agents: therapeutic use | Urology and Nephrology
Journal Article
The Lancet, ISSN 0140-6736, 09/2005, Volume 366, Issue 9489, pp. 895 - 906
The apparent shortfall in prevention of coronary heart disease (CHD) noted in early hypertension trials has been attributed to disadvantages of the diuretics... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | MANAGEMENT | MORBIDITY | DISEASE | GUIDELINES | DOUBLE-BLIND | CALCIUM-ANTAGONISTS | HYPERTENSION | INTERVENTION | Calcium Channel Blockers - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Bendroflumethiazide - administration & dosage | Hypertension - drug therapy | Male | Perindopril - administration & dosage | Sodium Chloride Symporter Inhibitors - administration & dosage | Diuretics | Adrenergic beta-Antagonists - adverse effects | Adult | Female | Blood Pressure - drug effects | Atenolol - administration & dosage | Drug Therapy, Combination | Amlodipine - administration & dosage | Adrenergic beta-Antagonists - administration & dosage | Risk Factors | Amlodipine - adverse effects | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Antihypertensive Agents - adverse effects | Coronary Disease - prevention & control | Calcium Channel Blockers - administration & dosage | Atenolol - adverse effects | Hypertension - complications | Aged | Hypertension | Antihypertensive drugs | Evaluation | Dosage and administration | Drug therapy | Prevention | Drug therapy, Combination | Health aspects | Coronary heart disease | Risk factors | Studies | Drugs | Cardiovascular disease | Medical treatment | Myocardial infarction | Heart attacks | Clinical trials | Family medical history | Blood | Randomization | Motivation | Blood pressure | Heart diseases | Antihypertensive agents | Cerebral infarction | Stroke | Fasting | Mortality | Diabetes mellitus | Health risks | Triglycerides | Metabolism | Risk analysis | Atenolol | Fatal | Patients | Coronary artery disease | Cholesterol | Heart rate | Infarction | Diabetes | Cardiovascular diseases | Health risk assessment | Potassium | Amlodipine/administration & dosage/adverse effects | Bendroflumethiazide/administration & dosage | Cardiovascular Diseases/prevention & control | Perindopril/administration & dosage | MEDICIN OCH HÄLSOVETENSKAP | Atenolol/administration & dosage/adverse effects | Combination | Antihypertensive Agents/administration & dosage/adverse effects | Angiotensin-Converting Enzyme Inhibitors/administration & dosage | MEDICAL AND HEALTH SCIENCES | Coronary Disease/prevention & control | Drug Therapy | Adrenergic beta-Antagonists/administration & dosage/adverse effects | Blood Pressure/drug effects | Hypertension/complications/drug therapy | Calcium Channel Blockers/administration & dosage/adverse effects | Sodium Chloride Symporter Inhibitors/administration & dosage
Journal Article
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 09/2014, Volume 96, Issue 3, pp. 349 - 359
The suitability of the capillary dried blood spot (DBS) sampling method was assessed for simultaneous phenotyping of cytochrome P450 (CYP) enzymes and... 
P4502B6 ACTIVITY | VORICONAZOLE | LC-MS/MS | SINGLE-POINT | ORAL MIDAZOLAM | VOLUNTEERS | IN-VIVO | PHARMACOLOGY & PHARMACY | DRUG-METABOLIZING-ENZYMES | KAROLINSKA COCKTAIL | BUPROPION HYDROXYLATION | Predictive Value of Tests | Pharmaceutical Preparations - blood | Caffeine - administration & dosage | Cytochrome P-450 Enzyme Inhibitors | Dried Blood Spot Testing | Humans | Omeprazole - blood | Bupropion - blood | Midazolam - administration & dosage | Substrate Specificity | Male | Chromatography, High Pressure Liquid | ATP-Binding Cassette, Sub-Family B, Member 1 - antagonists & inhibitors | Coffee | Terfenadine - administration & dosage | Caffeine - pharmacokinetics | Feasibility Studies | Enzyme Inhibitors - administration & dosage | Young Adult | Chromatography, Reverse-Phase | Tandem Mass Spectrometry | Capsules | Spectrometry, Mass, Electrospray Ionization | Flurbiprofen - administration & dosage | Adult | Dextromethorphan - pharmacokinetics | Terfenadine - blood | ATP-Binding Cassette, Sub-Family B, Member 1 - blood | Pharmaceutical Preparations - administration & dosage | Terfenadine - pharmacokinetics | Bupropion - pharmacokinetics | Flurbiprofen - pharmacokinetics | Cytochrome P-450 Enzyme System - blood | Administration, Oral | Isoenzymes | Caffeine - blood | Omeprazole - administration & dosage | Terfenadine - analogs & derivatives | Omeprazole - pharmacokinetics | Carbonated Beverages | Midazolam - pharmacokinetics | Bupropion - administration & dosage | Dextromethorphan - blood | Flurbiprofen - blood | Phenotype | Pilot Projects | Midazolam - blood | Dextromethorphan - administration & dosage | Usage | Glycoproteins | Liquid chromatography | Research | Pharmacokinetics | Cytochrome P-450 | Index Medicus | Abridged Index Medicus
Journal Article
Vaccine, ISSN 0264-410X, 2014, Volume 32, Issue 23, pp. 2732 - 2739
Highlights • A single dose of high titer MVA vaccine was compared to 1 or 2 standard doses. • High dose MVA was safe and well-tolerated. • Median time to... 
Allergy and Immunology | IMVAMUNE | Plaque reduction neutralizing antibody | Smallpox | Variola | MVA | Vaccine | ELISA | Analysis | Enzyme-linked immunosorbent assay | vaccine | plaque reduction neutralizing antibody | smallpox
Journal Article
The Journal of Clinical Hypertension, ISSN 1524-6175, 04/2018, Volume 20, Issue 4, pp. 705 - 715
Fixed‐dose combinations (FDC) have been developed to reduce the pill burden for hypertensive patients. Data on fixed‐dose or free‐dose (freeDC)... 
fixed‐dose combination | angiotensin receptor blocker | calcium antagonist | angiotensin‐converting enzyme inhibitor | hypertension | adherence | fixed-dose combination | angiotensin-converting enzyme inhibitor | Hypertension | Dosage and administration | Enzyme inhibitors | Analysis
Journal Article
Journal Article
Journal Article